ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 56 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 2.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,426,000 | +8465.0% | 8,052,073 | +12826.3% | 0.58% | +7187.5% |
| Q4 2016 | $40,000 | -95.5% | 62,292 | -88.9% | 0.01% | -95.3% |
| Q4 2014 | $884,000 | -17.7% | 559,624 | 0.0% | 0.17% | -22.9% |
| Q3 2014 | $1,074,000 | -43.4% | 559,624 | 0.0% | 0.22% | -25.7% |
| Q2 2014 | $1,897,000 | +1.2% | 559,624 | 0.0% | 0.30% | +3.1% |
| Q1 2014 | $1,875,000 | +10929.4% | 559,624 | 0.0% | 0.29% | +9600.0% |
| Q4 2013 | $17,000 | -99.2% | 559,624 | 0.0% | 0.00% | -99.2% |
| Q3 2013 | $2,250,000 | – | 559,624 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |